DNA mismatch repair (MMR) is critical for maintaining mitotic and meiotic genomic integrity. MMR malfunction causes cancer through a mutator phenotype called microsatellite instability (MSI) and failure to initiate apoptosis. Our previous studies revealed strong associations between MLH3 and both human and mouse colorectal cancer (CRC) susceptibility loci. Subsequently, MLH3 mutations were identified in atypical Hereditary Non-Polyposis Colon Cancer families, and CRCs demonstrated to harbor somatic MLH3 mutations. However, the relatively small number of families identified with MLH3 mutations to date has made ambiguous whether MLH3 deficiency is associated with MSI-L or MSI-H tumor subtypes, and what the precise spectrum of cancer susceptibility attributable to MLH3 mutations really is. In the Preliminary Data section, we present evidence Mlh3, like Mlhl, performs unique meiotic MMR functions in both male and female germ cells. Our hypothesis is that Mlh3 similarly performs unique mitotic MMR functions in mammals, but that the cancer susceptibility spectrum and MSI phenotype of MLH3 deficiency have not been clearly defined. We therefore propose the following Specific Aims:1. To determine the expression pattern of Mlh3 protein in mouse gastrointestinal, lymphoid and other epithelial tissues. Characterization of the precise temporal and spatial Mlh3 expression pattern will provide important clues to its biological functions and a foundation for further studies.2. To determine the Microsatellite Instability phenotype of Mlh3 / tissues. These analyses wilt help prioritize patients and tumors exhibiting MSI-Low or MSI-High subtypes for future MLH3 mutation analyses.3. To determine the cancer susceptibility spectrum of Mlh3 -/- and Mlh3-/-/Pms2-/- mice. Our hypothesis is that Mlh3-/- mice are susceptible to cancer. Cognizant of the alternative hypothesis Mlh3 and Pms2 are redundant in mitotic MMR, we will analyze cancer susceptibility in Mlh3-/-/Pms2-/- mice.4. To quantify the effect of Mlh3 deficiency on bowel carcinoma formation. We propose generating Mlh3-/- Apc A1638Nmice and performing quantitative analyses of bowel cancer formation. The onset and progression of tumor formation will make possible direct comparisons with other MMR genes in future studies.The comments in the CRITIQUE section were prepared by the reviewers assigned to this application and are provided without significant modification or editing by staff. The RESUME AND SUMMARY OF DISCUSSION section documents the final outcome of the evaluation by reviewers and is the basis for the assigned priority score

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA098626-01A2S1
Application #
6948371
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Rosenfeld, Bobby
Project Start
2004-09-01
Project End
2009-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
1
Fiscal Year
2004
Total Cost
$47,980
Indirect Cost
Name
University of California Irvine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Chen, Huanhuan Joyce; Sun, Jian; Huang, Zhiliang et al. (2015) Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol 33:656-60
Benoit, Yannick D; Witherspoon, Mavee S; Laursen, Kristian B et al. (2013) Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells. Exp Cell Res 319:1463-70
Chen, Huanhuan Joyce; Edwards, Robert; Tucci, Serena et al. (2012) Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis. J Clin Invest 122:3184-96
Wang, Xiujuan; Wei, Xiaomu; Thijssen, Bram et al. (2012) Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol 30:159-64
Jahid, Sohail; Sun, Jian; Edwards, Robert A et al. (2012) miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov 2:540-53
Sikandar, Shaheen; Dizon, Diana; Shen, Xiling et al. (2010) The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling. Oncotarget 1:596-605
Jahid, Sohail; Lipkin, Steven (2010) Mouse models of inherited cancer syndromes. Hematol Oncol Clin North Am 24:1205-28
Edwards, Robert A; Witherspoon, Mavee; Wang, Kehui et al. (2009) Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. Cancer Res 69:6423-9
Chen, Peng-Chieh; Kuraguchi, Mari; Velasquez, John et al. (2008) Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression. PLoS Genet 4:e1000092
Shin, Brian Y; Chen, Huiping; Rozek, Laura S et al. (2005) Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patients. Dis Colon Rectum 48:1723-7

Showing the most recent 10 out of 11 publications